Correlation Between Hansa Biopharma and I Tech

Can any of the company-specific risk be diversified away by investing in both Hansa Biopharma and I Tech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hansa Biopharma and I Tech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Hansa Biopharma AB and I Tech, you can compare the effects of market volatilities on Hansa Biopharma and I Tech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hansa Biopharma with a short position of I Tech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hansa Biopharma and I Tech.

Diversification Opportunities for Hansa Biopharma and I Tech

0.4

Correlation Coefficient

Hansa Biopharma  I Tech

Very weak diversification

The 3 months correlation between Hansa and ITECH is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Hansa Biopharma AB and I Tech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on I Tech and Hansa Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hansa Biopharma AB are associated (or correlated) with I Tech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of I Tech has no effect on the direction of Hansa Biopharma i.e., Hansa Biopharma and I Tech go up and down completely randomly.

Pair Corralation between Hansa Biopharma and I Tech

Assuming the 90 days trading horizon Hansa Biopharma is expected to generate 1.89 times less return on investment than I Tech. In addition to that, Hansa Biopharma is 1.76 times more volatile than I Tech. It trades about 0.08 of its total potential returns per unit of risk. I Tech is currently generating about 0.25 per unit of volatility. If you would invest  7,899  in I Tech on April 20, 2025 and sell it today you would earn a total of  3,451  from holding I Tech or generate 43.69% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Hansa Biopharma AB  vs.  I Tech

Hansa Biopharma AB

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Hansa Biopharma AB are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Hansa Biopharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

I Tech

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in I Tech are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, I Tech unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Hansa Biopharma and I Tech

The main advantage of trading using opposite Hansa Biopharma and I Tech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hansa Biopharma position performs unexpectedly, I Tech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in I Tech will offset losses from the drop in I Tech's long position.

The idea behind Hansa Biopharma AB and I Tech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.